Xie, Jingjing

LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration

Deng, M., Gui, X., Kim, J., Xie, L., Chen, W., Li, Z., He, L., Chen, Y., Chen, H., Luo, W., et al. (2018) · Nature

Immune Cell Function and InteractionCancer Immunotherapy and Biomarkers

Cited by 305

Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation

Zhu, G., Xie, J., Kong, W., Xie, J., Li, Y., Du, L., Zheng, Q., Sun, L., Guan, M., Li, H., et al. (2020) · Cell

Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling

Cited by 267

Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer

Deng, M., Chen, H., Liu, X., Huang, R., He, Y., Yoo, B., Xie, J., John, S., Zhang, N., An, Z., et al. (2021) · Antibody Therapeutics

Immune Cell Function and InteractionCancer Immunotherapy and Biomarkers

Cited by 53

LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development

Huang, R., Liu, X., Kim, J., Deng, H., Deng, M., Gui, X., Chen, H., Wu, G., Xiong, W., Xie, J., et al. (2024) · Cancer Immunology Research

Cancer Immunotherapy and BiomarkersImmune cells in cancer

Cited by 24

Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptors

Zhang, C., He, Y., Liu, X., Xie, J., Fang, M., Yang, X., Huang, R., Lou, Q., Li, B., Gupta, A., et al. (2025) · Signal Transduction and Targeted Therapy

Cancer Immunotherapy and BiomarkersProtease and Inhibitor Mechanisms

Cited by 2